Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03759119 · ClinicalTrials.gov registry record · NA

Use of a Tummy Time Intervention and Parent Education in Infants Born Preterm

A NA study, sponsored by University of Indianapolis.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT03759119: Completed NA study, sponsored by University of Indianapolis.

NCT03759119 is a NA study that has completed, run by University of Indianapolis. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03759119, a NA study, has completed, sponsored by University of Indianapolis.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The purpose of this research study is to see if tummy time and parent education helps motor development among infants born preterm. Participants will be recruited from Ann and Robert H. Lurie Children's Hospital of Chicago neonatal intensive care unit.

Primary Outcome

The TIMP is a functional motor scale for newborns, including those born premature, up to infants four months corrected age, and was specifically designed for use in neonatal intensive care units (Rose \& Westcott, 2005).

Interventions

  • BEHAVIORAL Tummy time and parent education
  • BEHAVIORAL Parent education only

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2019-02-06
Est. Completion 2020-03-23
Phase NA
University of Indianapolis

9 total trials

What the finished NCT03759119 record still lists

NCT03759119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Tummy time and parent education is the first listed.

NCT03759119 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03759119 about?

NCT03759119 is a clinical study titled "Use of a Tummy Time Intervention and Parent Education in Infants Born Preterm". The purpose of this research study is to see if tummy time and parent education helps motor development among infants born preterm. Participants will be recruited from Ann and Robert H. Lurie Children's Hospital of Chicago neonatal intensive care unit.

What is the current status of trial NCT03759119?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-02-06. Estimated completion is 2020-03-23.

What interventions are being tested in trial NCT03759119?

The interventions under investigation include: Tummy time and parent education (BEHAVIORAL), Parent education only (BEHAVIORAL).

Who is sponsoring clinical trial NCT03759119?

This trial is sponsored by University of Indianapolis, which has 9 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03759119's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03759119, the US trial registry maintained by the National Library of Medicine. NCT03759119 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.